NASDAQ:CPRX
CPRX short interest surges, indicating growing pessimism among investors
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its ...
CPRX’s latest rating updates from top analysts.
Catalyst Pharmaceuticals Inc’s filing revealed that its Chief Commercial Officer Del Carmen Jeffrey unloaded Company’s shares for reported $0.26 million ...
Analysts optimistic about CPRX’s future growth prospects
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or ...
CPRX’s short interest shows a sharp decline on 2025-10-31
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or ...
Recent Insider Activity Could Benefit Catalyst Pharmaceuticals Inc (CPRX)
Catalyst Pharmaceuticals Inc’s filing revealed that its Chief Compliance/Legal Officer Elsbernd Brian unloaded Company’s shares for reported $0.61 million on ...
Catalyst Pharmaceuticals Inc (CPRX) rating initates by Robert W. Baird
In a filing, Catalyst Pharmaceuticals Inc revealed its Chief Compliance/Legal Officer Elsbernd Brian unloaded Company’s shares for reported $0.61 million ...
Selling Buzz: Catalyst Pharmaceuticals Inc [CPRX] Chief Compliance/Legal Officer Elsbernd Brian sells 30,000 shares of the company
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its ...
